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Abstract
Background: Degenerative granular structures appear progressively with age in the hippocampus of most mouse
strains. We recently reported that these granules contain a neo-epitope that is recognised by IgM antibodies
present as contaminants in many commercial antibodies obtained from mouse ascites and mouse or rabbit serum.
We hypothesise that these anti-neo-epitope IgMs are in fact natural auto-antibodies that are generated
spontaneously during the foetal stage without previous contact with external antigens and whose repertoire and
reactivity pattern have been determined through evolution, being remarkably stable within species and even
between species.
Findings: In the present work we found that mice from the ICR-CD1, BALB/C and SAMP8 strains have anti-neo-
epitope IgM antibodies in their plasma at all ages tested and even when maintained under specific opportunistic
pathogen-free conditions. Moreover, we determined that these anti-neo-epitope IgMs are also present in rabbit,
goat and rat serum. We also found that, in each mouse that presented hippocampal granules, the anti-neo-epitope
IgMs contained in its plasma recognised the neo-epitopes in its own granules.
Conclusions: This study led to the conclusion that anti-neo-epitope IgMs are widespread natural auto-antibodies
contained in the plasma of mice and other species. The presence of these natural auto-antibodies not only explains
why they are frequently found as contaminants in commercial antibodies, but also paves the way for a new
approach to a treatment and diagnosis of pathological brain processes based on natural IgMs and neo-epitopes.
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Findings
Introduction
Pathological granular structures, originally described as
periodic acid-Schiff granules due to their reactivity to
this staining, appear progressively with age in the hippo-
campus of most mouse strains, especially in the
senescence-accelerated mouse prone 8 (SAMP8) strain
[1–4]. They are round-to-ovoid structures that measure
up to 3 μm in diameter and tend to form clusters, each
with approximately 40–50 granules [1, 4, 5]. The ultrastruc-
tural analysis of the granules showed a central electron-
dense core formed by an accumulation of membranous
fragments and a peripheral zone, or halo, externally delim-
ited by a slightly discontinuous plasma membrane. The per-
ipheral zone contains degenerating organelles, especially
mitochondria, and unstable membranous structures that
lead to the formation of blebs or bubbles, which cover an
extensive area of this zone [2, 5–7]. In recent studies, we
observed that these granules are formed by degenerative
mechanisms that occur mainly in astrocytic processes, with
each affected astrocyte generating one cluster of granules
[8]. This degenerative process can also affect the structures
of the surrounding neuropil, including neuronal structures
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such as synaptic buttons and dendritic spines [8]. In an-
other recent study, we reported the presence of specific epi-
topes in the granules that are not present in healthy brain
structures and are formed at the same time as the granules,
which led us to conclude that they were neo-epitopes [9].
These neo-epitopes are mainly located in the membranous
fragments of the centre of the granules, although during
the granule formation they can also be found in the
membranes of the adjacent neuropil. Moreover, we
showed that this neo-epitope is recognised by con-
taminant IgM antibodies present in many commercial
antibodies obtained from mouse ascites and mouse or
rabbit serum.
All these findings suggest that the contaminant IgMs
found in antibodies obtained from mouse serum and asci-
tes and directed against the neo-epitope could in fact be
natural auto-antibodies. Natural antibodies are generated
spontaneously from the foetal stage without previous con-
tact with external antigens [10, 11]. Their repertoire and
reactivity pattern have been determined through evolution
and are remarkably stable within species and even between
species [12, 13]. They constitute a first line of immune de-
fence and also have other important functions in the
physiology of the organism. Some of these natural anti-
bodies are able to recognise the neo-epitopes that are
formed, for example, in cell remnants or in apoptotic or al-
tered cells, and thus intervene in their controlled elimin-
ation [12]. Consequently, we hypothesise that mouse
plasma contains natural IgM auto-antibodies that recog-
nise the neo-epitopes present in the degenerative hippo-
campal granular structures formed with ageing.
If our hypothesis is correct and the anti-neo-epitope
IgMs are natural antibodies, all mice of the different
strains should have anti-neo-epitope IgMs in their blood
plasma at all ages, regardless of any previous exposure
to external pathogens, or whether the animals develop
pathological granular structures in their hippocampus or
not. Moreover, they are probably also found in the plasma
of mammals other than mice. Besides, in order to consider
them as auto-antibodies, it is necessary to demonstrate that
the anti-neo-epitope IgMs in the plasma of animals with
granules recognise the neo-epitopes in their own granules.
Methods
Mice
Male SAMP8, ICR-CD1 and Balb/cOlaHsd (BALB/C)
mice aged from 1 to 15-month were used. These strains
were selected because their progressive formation of hip-
pocampal granule clusters is accelerated, moderate or
nearly absent, respectively. ICR-CD1 and SAMP8 mice
were obtained from the Servei d’Estabulari de la Facultat
de Farmàcia (Universitat de Barcelona), while BALB/C
mice were obtained from Harlan Laboratories Models
(Sant Feliu de Codines, Spain). Animals were kept under
standard temperature conditions (22 ± 2 °C) and 12:12 h
light–dark cycles (300 lux / 0 lux), and had access to
food and water ad libitum throughout the study. We
also used 3-month-old male ICR-CD1 (Janvier Labs, Le
Genest-Saint-Isle, France) and BALB/C mice (Harlan La-
boratories Models), which were kept under specific op-
portunistic pathogen-free (SOPF) conditions from birth
and until the day of sacrifice. All experimental proce-
dures were reviewed and approved by the University of
Barcelona Animal Experimentation Ethics Committee
(DAAM 7504).
Serum obtention and brain removal and processing
One to nine-months-old SAMP8, ICR-CD1 and BALB/C
mice (4–6 animals per group) were anaesthetised i.p.
with sodium pentobarbital (80 mg/kg), the thoracic cage
was opened and blood was obtained by cardiac punc-
ture. Blood was left to clot, centrifuged at 14,850 rpm
for 5 min in a Biofuge Pico centrifuge (Heraeus, Madrid,
Spain), and serum was collected and stored at −80 °C
until use. After cardiac puncture, animals received an in-
tracardiac gravity-dependent perfusion of 50 mL saline
solution (0.9 % NaCl). Brains were dissected and cryo-
static brain sections were obtained as described previ-
ously [8]. Some brain sections from 12 and 15-month-
old ICR-CD1 mice were obtained following the same
procedure, but without the cardiac puncture to obtain
blood, in order to obtain hipocampal sections with de-
generative granules.
Immunohistochemical staining for fluorescence
microscopy and image acquisition
In order to determine if the plasma of the animals (in-
cluding those born and maintained in SOPF conditions)
contained anti-neo-epitope IgMs, immunohistochemical
staining procedures were performed on brain sections
from 12 or 15-months-old ICR-CD1 animals by using
the mouse serum in the first incubation and an anti-
mouse IgM conjugated to a fluorocrom as a secondary
antibody. The staining was performed as follows. Sections
were rehydrated with PBS and then blocked and permea-
bilised with 1 % bovine serum albumin (Sigma-Aldrich)
and 0.1 % Triton X-100 (Sigma-Aldrich) in PBS for
20 min. They were washed with PBS and the primary in-
cubation was performed overnight at 4 °C with a solution
containing both a mouse serum diluted 1/100 and the
rabbit anti-MMP2 IgG antibody (Merck Millipore, Darm-
stadt, Germany) diluted 1/200 in blocking buffer (BB; 1 %
bovine serum albumin in PBS). The anti-MMP2 antibody
was added as a specific marker of the granules, as we pre-
viously described [9]. Thereafter, slides were washed again
and incubated for 1 h with a solution containing 1/50 tet-
ramethyl rhodamine-conjugated (TRITC) goat anti-mouse
IgM (Jackson ImmunoResearch Laboratories, Newmarket,
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UK) and 1/250 AlexaFluor (AF)-488-conjugated donkey
anti-rabbit IgG antibody (Life Technologies, Carlsbad,
CA) in BB. Nuclear staining was performed with Hoechst
(2 μg/mL, H-33258, Fluka, Madrid, Spain). The slides
were coverslipped with Fluoromount (Electron Micros-
copy Sciences, Hatfield, PA, USA). As the positive control
for the anti-neo-epitope IgM staining of the granules the
anti-neo-epitope IgMs contained as a contaminant in the
OX52 antibody (obtained from mouse ascites) were
used instead of the animal serum. Negative controls
were performed with a first incubation without mouse
serum. To verify that the anti-neo-epitope IgMs con-
tained in mouse serum were auto-antibodies, we per-
formed the same immunohistochemical procedure
detailed above but on brain sections of the same ani-
mal that provided the serum instead of the brain sec-
tions from aged ICR-CD1 animals.
To determine the presence of the anti-neo-epitope IgMs
in the serum of other species than mouse we performed
the same immunohistochemical staining procedures by
using rat serum (obtained from our laboratory), rabbit
serum and goat serum (both from Jackson ImmunoRe-
search Laboratories) at a 1/50 dilution instead of mouse
serum. AF-594-conjugated goat anti-rat IgM (Life Tech-
nologies), fluorescein isothiocyanate (FITC)-conjugated
goat anti-rabbit IgM, FITC-conjugated rabbit anti-goat
IgM (Abcam, Cambridge, UK) and AF-555-conjugated
donkey anti-rabbit IgG (Life Technologies) were used at a
dilution 1/250 in the secondary incubations.
In all cases, fluorescence images were taken with a fluor-
escence laser microscope BX41 (Olympus, Germany) and
images where stored in tiff format. Image compositions
were performed with the ImageJ programme (National In-
stitute of Health, USA).
Fig. 1 Sera from SAMP8, ICR-CD1 and BALB/C mice contain anti-neo-epitope IgMs. Representative images of the hippocampal region of brain
sections from 15-month-old ICR-CD1 mice simultaneously stained with Hoechst (blue), anti-MMP-2 antibody (green) and mouse sera (red) from
each experimental group as detailed next. a-c: Sera from SAMP8 mice aged 1, 3 and 6 months, respectively. d-g: Sera from ICR-CD1 mice aged 1,
3, 6 and 9 months, respectively. h: Serum from a BALB/C mouse aged 3 months. i: Control staining of the granules with anti-neo-epitope IgMs
contained in the OX52 antibody. In all cases the anti-MMP-2 staining showed the clusters of granules. Some granules of the clusters are stained
with the serum, indicating that all sera contained anti-neo-epitope IgMs. Scale bar: 50 μm
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Results
In order to determine whether the anti-neo-epitope IgMs
are natural antibodies we first examined their presence in
the serum of mice from different strains at different ages,
i.e., 1, 3, 6 and 9 month-old ICR-CD1 mice, 1, 3 and
6 month-old SAMP8 mice and 3 month-old BALB/C
mice (n = 4–6 per group). The IgM presence was evalu-
ated by immunostaining brain sections from 15-month-
old ICR-CD1 mice with the mouse sera and the anti-
MMP2 antibody. In all cases the sera stained hippocampal
granules, which are also labelled with the anti-MMP2
antibody, indicating that all tested mouse sera contained
the anti-neo-epitope IgMs (Fig. 1a–h). In the positive con-
trol performed with the anti-neo-epitope IgMs contained
in the OX52 antibody, granules were also stained (Fig. 1i).
On the other hand, as natural antibodies are present
regardless of any previous exposure to external patho-
gens, we also tested for the presence of the anti-neo-
epitope IgMs in the serum of 3-month-old ICR-CD1
and BALB/C mice maintained under SOPF conditions
(n = 6 per group). All mouse sera positively stained the
hippocampal granules contained in the brain sections
from 15-month-old ICR-CD1 mice, which are also la-
belled with the anti-MMP2 antibody (Fig. 2), indicating
that mice kept under SOPF conditions contained the
anti-neo-epitope IgMs in their plasma.
Furthermore, as natural antibodies are remarkably
stable not only within species but even between species,
we also tested the presence of these IgMs in the serum
of species other than mice. Thus, we immunostained
brain sections of a 12-month old ICR-CD1 mouse with
rat, rabbit and goat serum. In all cases the granules were
positively stained, which indicated that the serum of the
different species assayed contained the anti-neo-epitope
IgMs (Fig. 3).
On the other hand, in order to establish whether the
anti-neo-epitope IgM is an auto-antibody, brain sections
from each mouse were immunostained with its own sera
combined with the staining with the anti-MMP2 anti-
body. In the cases in which MMP2 indicated the pres-
ence of granules, the granules were also stained with the
own serum, indicating that the anti-neo-epitope IgM
contained in serum is an auto-antibody that recognises
the own hippocampal granules (Fig. 4). It must be
pointed out that some young animals, especially BALB/
C mice, do not present granules in their hippocampus
and thus the staining of the granules with their own
Fig. 2 Previous contact with external pathogens is not necessary for
the presence of anti-neo-epitope IgMs in mouse serum. Representative
images of the hippocampal region of brain sections from 12-month old
ICR-CD1 mice simultaneously stained with Hoechst (blue), anti-MMP-2
antibody (green) and sera (red) from a 3-month-old ICR-CD1 SOPF ani-
mal (a) or from a 3-month-old BALB/C SOPF animal (b). In both cases
the anti-MMP-2 staining showed the clusters of granules. Some granules
of the clusters are stained with the serum, indicating that the sera of
SOPF animals contained anti-neo-epitope IgMs. Scale bar: 50 μm
Fig. 3 Anti-neo-epitope IgMs are present in the serum from other
species than mice. Representative images of the hippocampal region of
brain sections from 12-month-old ICR-CD1 mice simultaneously stained
with Hoechst (blue), anti-MMP-2 antibody and rabbit (a), rat (b) and goat
(c) serum. Clusters of granules can be observed with the anti-
MMP-2 staining (red in a and c and green in b) and some gran-
ules of the clusters are stained with the different sera (green in a and
c and red in b), which indicates that the serum of these species con-
tained anti-neo-epitope IgMs. Scale bar: 50 μm
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IgMs cannot be tested. Moreover, as all sera from all
ages contain anti-neo-epitope IgMs, these results also in-
dicate that the presence of the granules in the brain is
not necessary for the existence of the anti-neo-epitope
IgMs in the plasma.
Moreover, it should be pointed out that, under physio-
logical conditions, the IgMs present in mouse plasma do
not reach the granules of the hippocampus. The immuno-
staining with a primary incubation containing only the
antibody directed against MMP2 and a secondary incuba-
tion with antibodies directed against the anti-MMP2 and
against the mouse IgMs show the clusters of granules
stained with the anti-MMP2 antibody but not with the
anti-IgM antibody (Fig. 5). Thus, the anti-neoepitope IgMs
existing in the plasma of the animals do not have access
to the brain neo-epitopes.
Discussion and conclusions
The results of this study led us to conclude that the
IgMs directed against the neo-epitope are common nat-
ural auto-antibodies that are always contained in mouse
plasma independently of the existence of granules in the
brain, and are also present in plasma of species other
than mouse.
The presence of both these neo-epitopes in the gran-
ules and the natural anti-neo-epitope IgMs could be due
to the fact that the neo-epitopes are formed by widespread
mechanisms related to pathological ageing processes such
as those associated with the increase of oxidative stress
caused by the production of reactive oxygen or nitrogen
species. Note that the number of granules seems to be
modulated by antioxidant treatments or increases in oxi-
dative stress [5, 14–16]. Oxidative stress may cause ad-
vanced glycation end products or oxidised phospholipids,
which are a target of natural auto-antibodies and may trig-
ger immune responses aimed at eliminating them and re-
moving the structures that contain them [17–19].
Oxidation-specific epitopes have been documented in
some pathological situations as in atherosclerotic lesions
but also in pulmonary, renal and liver diseases as well as
central nervous system lesions of multiple sclerosis and
Alzheimer disease. Moreover, cells undergoing apoptosis
have also been shown to contain multiple oxidation-
specific epitopes in their plasma membranes. Therefore,
oxidation-specific epitopes constitute perfect tags for the
identification of biological waste and the discrimination
of dying cells from viable cells by specific immune re-
sponses [20]. From this point of view, we can consider
that the neo-epitopes found in the granules of the hippo-
campus of aged mice and the presence of natural anti-
neo-epitope IgMs in their plasma could be related to a
general mechanism that is effective in some tissues. How-
ever, the brain avoids these responses, probably due to the
existence of the blood–brain barrier. It is worth noting
that natural IgMs and neo-epitopes that have received lit-
tle attention are now back on stage, as demonstrated by a
Fig. 4 Anti-neo-epitope IgMs are auto-antibodies. Representative images of the hippocampal region of brain sections from different mice stained
with their own serum (red) and both the anti-MMP2 antibody (green) and Hoechst (blue). a-c: Representative ICR-CD1 mice aged 3, 6 and 9 months,
respectively. d-f: Representative SAMP8 mice aged 3 and 6 months. As can be observed, the granules are stained by the serum of the own mouse.
Thus, each serum recognize the own neo-epitope present in its clusters of granules. Scale bar: 50 μm
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new field of activity relating to the diagnosis and treat-
ment of some cancers based on the presence of specific
tumour neo-epitopes, which can be recognised by natural
IgMs [21–23]. The results of this study led us to believe
that treatment and diagnostics based on natural IgMs and
neo-epitopes can probably be extended to brain diseases
and pathological processes that occur in the brain, and
could therefore pave the way for a new field of study in
this area.
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